Table 4.

Results from the clinical blood and urine analyses.

	AM operators		Controls (n = 20)
	All (n=18)	Only FDM/ME (n = 10)
ASAT (μkat/L)	0.49 (0.37, 0.69)	0.47 (0.37, 0.50)	0.41 (0.36, 0.50)
ALAT (μkat/L)	0.40 (0.24, 0.49)	0.35 (0.23, 0.45)	0.26 (0.22, 0.41)
ALP (μkat/L)	1.02 (0.77, 1.14)	1.02 (0.82, 1.09)	0.88 (0.78, 1.13)
ApoA1 (g/L)	1.36 (1.29, 1.44)	1.36 (1.29, 1.44)*	1.45 (1.35, 1.71)
ApoB (g/L)	0.96 (0.86, 1.09)	0.87 (0.81, 1.00)	0.84 (0.73, 1.10)
ApoB/ApoA1	0.71 (0.62, 0.79)	0.66 (0.52, 0.78)	0.61 (0.44, 0.74)
SAA1/PON1 (ng/U)	15.2 (9.11, 22.8)	18.6 (9.11, 22.6)	9.26 (7.39, 15.9)
U-α1M (mg/L)	0.47 (0.32, 0.73)	0.55 (0.39, 0.73)	0.4 (0.23,0.54)

Medians and interquartile ranges are listed. *Significantly different from the control group, p < 0.05.